Dr. Jean-Pierre Valentin UCB, Belgium

Dr. Jean-Pierre Valentin is a scientist with over 30 years of experience in the pharmaceutical industry, specializing in drug discovery, safety pharmacology, and investigative toxicology. He earned his Ph.D. in Physiology and Pharmacology from the University of Montpellier, France, followed by postdoctoral research at the University of California, San Francisco.... read more

Dr. Valentin began his career at the Pierre Fabre Research Centre, contributing to the discovery and development of three drug candidates. He later joined AstraZeneca, where he established and led the Department of Safety Pharmacology, supporting the safety assessment of approximately 200 candidate drugs across multiple therapeutic areas. His work contributed to the development and registration of several marketed products.

In 2014, he joined UCB-Biopharma as Senior Director and Head of Investigative Toxicology, overseeing safety science across the company’s portfolio and modalities.

He is a former President of the Safety Pharmacology Society and serves as co-chair of both the HESI Proarrhythmia Subcommittee and the HESI Cardiac Steering Team. He is also a member of the Board of Trustees and Executive Committee of HESI, Chair of the IQ-DruSafe Secondary Pharmacology Working Group, and EFPIA representative on the ICH E14-S7B committee.

Dr. Valentin is actively involved in education and mentoring through scientific societies, universities, and industry associations. He has authored or co-authored several patents and over 250 peer-reviewed publications and book chapters.